CN1943707A - 一种用于抗衰老的中药组合物及其制备方法 - Google Patents
一种用于抗衰老的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1943707A CN1943707A CN 200510105965 CN200510105965A CN1943707A CN 1943707 A CN1943707 A CN 1943707A CN 200510105965 CN200510105965 CN 200510105965 CN 200510105965 A CN200510105965 A CN 200510105965A CN 1943707 A CN1943707 A CN 1943707A
- Authority
- CN
- China
- Prior art keywords
- radix
- weight portions
- ginseng rubra
- chinese medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims description 12
- 230000003712 anti-aging effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 claims abstract description 26
- 241000208340 Araliaceae Species 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 230000007812 deficiency Effects 0.000 claims abstract description 9
- 206010033557 Palpitations Diseases 0.000 claims abstract description 5
- 206010037660 Pyrexia Diseases 0.000 claims abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims abstract description 5
- 208000009205 Tinnitus Diseases 0.000 claims abstract description 5
- 208000002173 dizziness Diseases 0.000 claims abstract description 5
- 206010022437 insomnia Diseases 0.000 claims abstract description 5
- 206010029410 night sweats Diseases 0.000 claims abstract description 5
- 230000036565 night sweats Effects 0.000 claims abstract description 5
- 231100000886 tinnitus Toxicity 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 6
- 208000000059 Dyspnea Diseases 0.000 claims description 4
- 206010013975 Dyspnoeas Diseases 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 208000013220 shortness of breath Diseases 0.000 claims description 4
- 230000002605 anti-dotal effect Effects 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- -1 aspartyl Chemical group 0.000 abstract 1
- 230000001544 dysphoric effect Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000000047 product Substances 0.000 description 16
- 230000032683 aging Effects 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000002490 cerebral effect Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical group NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008807 pathological lesion Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量/g·Kg-1 | SOD/U·mL-1 | MDA/nmol·mL-1 |
空白组模型组脑复康组本品大剂量组本品中剂量组本品小剂量组 | --0.400.800.400.16 | 152.48±12.33132.32±16.07*148.70±13.34△158.45±12.52△△149.82±10.79△147.77±12.11△★ | 5.45±2.016.74±1.12*5.39±1.51△△4.93±1.05△△5.00±1.24△△5.47±0.80△ |
组别 | 剂量/g·Kg-1 | GSHPX/mol·min-1 |
空白组模型组脑复康组本品大剂量组本品中剂量组本品小剂量组 | --0.400.800.400.16 | 269.05±25.59185.75±36.09*251.64±51.78△△255.13±24.48△△246.74±50.04△△204.92±55.81★ |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101059658A CN1943707B (zh) | 2005-10-08 | 2005-10-08 | 一种用于抗衰老的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005101059658A CN1943707B (zh) | 2005-10-08 | 2005-10-08 | 一种用于抗衰老的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1943707A true CN1943707A (zh) | 2007-04-11 |
CN1943707B CN1943707B (zh) | 2012-11-28 |
Family
ID=38043501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005101059658A Active CN1943707B (zh) | 2005-10-08 | 2005-10-08 | 一种用于抗衰老的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1943707B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579795A (zh) * | 2012-03-01 | 2012-07-18 | 正大青春宝药业有限公司 | 抗衰老中药组合物在制备改善男性生育功能药物中的应用 |
CN105381184A (zh) * | 2015-12-21 | 2016-03-09 | 钱得方 | 一种提高人体免疫力的中药丸剂 |
CN108524749A (zh) * | 2018-07-03 | 2018-09-14 | 正大青春宝药业有限公司 | 一种用于改善肠道菌群分布的中药组合物及应用 |
CN108567849A (zh) * | 2018-07-03 | 2018-09-25 | 正大青春宝药业有限公司 | 一种改善睡眠的组合物及其制剂 |
CN108815291A (zh) * | 2018-07-03 | 2018-11-16 | 正大青春宝药业有限公司 | 一种降低体脂率的组合物及其制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1080535A (zh) * | 1992-06-29 | 1994-01-12 | 赵奕成 | 八六八益智健脑智囊 |
CN1103799A (zh) * | 1994-07-13 | 1995-06-21 | 徐声浩 | 一种抗衰老延年益寿补剂及其制备方法 |
CN1094763C (zh) * | 1999-03-08 | 2002-11-27 | 李功彦 | 一种治疗疲劳补肾益脑的中药丸 |
CN1115156C (zh) * | 2000-04-17 | 2003-07-23 | 李熙德 | 一种抗衰老的中药 |
CN1398607A (zh) * | 2001-07-19 | 2003-02-26 | 黄安烈 | 可延缓衰老的药物及其制备方法 |
-
2005
- 2005-10-08 CN CN2005101059658A patent/CN1943707B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579795A (zh) * | 2012-03-01 | 2012-07-18 | 正大青春宝药业有限公司 | 抗衰老中药组合物在制备改善男性生育功能药物中的应用 |
CN102579795B (zh) * | 2012-03-01 | 2014-01-08 | 正大青春宝药业有限公司 | 抗衰老中药组合物在制备改善男性内分泌的药物中的应用 |
CN105381184A (zh) * | 2015-12-21 | 2016-03-09 | 钱得方 | 一种提高人体免疫力的中药丸剂 |
CN108524749A (zh) * | 2018-07-03 | 2018-09-14 | 正大青春宝药业有限公司 | 一种用于改善肠道菌群分布的中药组合物及应用 |
CN108567849A (zh) * | 2018-07-03 | 2018-09-25 | 正大青春宝药业有限公司 | 一种改善睡眠的组合物及其制剂 |
CN108815291A (zh) * | 2018-07-03 | 2018-11-16 | 正大青春宝药业有限公司 | 一种降低体脂率的组合物及其制剂 |
CN108815291B (zh) * | 2018-07-03 | 2021-06-11 | 正大青春宝药业有限公司 | 一种降低体脂率的组合物及其制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN1943707B (zh) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1943707B (zh) | 一种用于抗衰老的中药组合物及其制备方法 | |
CN112569305A (zh) | 一种提高免疫力的香菇复合多糖组合物及其制备方法 | |
CN115252692A (zh) | 中药组合物在制备与高尿酸相关疾病的药物中的应用 | |
CN113840613A (zh) | 具有预防和治疗激素依赖性皮炎功效的生物多糖及其应用 | |
CN110664883B (zh) | 一种具有生精作用的药物组合物 | |
CN1872094A (zh) | 海参活性物质作为药物或保健品的应用 | |
CN101647816B (zh) | 一种动物皮类的酶解产物及其用途 | |
CN101081250B (zh) | 一种改善贫血的何首乌提取物药剂及其制备方法和应用 | |
CN1049355C (zh) | 北冬虫夏草的加工方法 | |
CN1965951A (zh) | 驴胶补血胶囊及制备方法 | |
CN1401365A (zh) | 一种中药保健药物 | |
CN1255121C (zh) | 一种红景天药物制剂的制备方法 | |
CN1827128A (zh) | 一种双黄连阴道用药物及其制备方法 | |
CN1248698C (zh) | 一种治疗冠心病或冠心病合并心功能不全的药物及其制备方法 | |
CN111437287A (zh) | 榴莲皮多糖在制备免疫增强药物方面的应用 | |
CN1296087C (zh) | 用于治疗中风中经络风痰瘀阻的复方胶囊及其制备方法 | |
CN1943711A (zh) | 一种用于养心健脑的中药组合物及其制备方法 | |
CN1575803A (zh) | 一种库拉索芦荟提取物在预防和治疗糖尿病方面的应用方法 | |
CN102579801B (zh) | 一种治疗糖尿病综合症的中药制剂及其制备方法 | |
CN113368209B (zh) | 一种芪蛭胶囊在制备治疗原发性高血压药物中的新用途 | |
CN1269815C (zh) | 一种水飞蓟提取物葡甲胺盐的新制备方法 | |
CN1552409A (zh) | 一种治疗溃疡病的药物组合物及制法 | |
CN112891416B (zh) | 一种治疗银屑病的中药组合物 | |
CN101040982A (zh) | 一种中药降糖组合物 | |
US20030118663A1 (en) | Method and composition for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SUN ZHIQIANG Free format text: FORMER OWNER: ZHOU XIAOMING Effective date: 20121009 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100012 DONGCHENG, BEIJING TO: 250002 JINAN, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121009 Address after: 250002 Shandong city of Ji'nan province sunshine city 13 15-315 Applicant after: Sun Zhiqiang Address before: 100012, No. 10, Qinglong dragon alley, Dongcheng District, Beijing Applicant before: Zhou Xiaoming |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 250002 Shandong Province, Ji'nan City District Shungeng Road No. 217 NINETOWNS Shangdu office building room 324 Patentee after: Sun Zhiqiang Address before: 250002 Shandong city of Ji'nan province sunshine city 13 15-315 Patentee before: Sun Zhiqiang |
|
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Feng He Inventor before: Zhou Xiaoming |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160818 Address after: 310021 No. 551, Xixi Road, Hangzhou, Zhejiang Patentee after: Zhengda Qingchunbao Pharmaceutical Co., Ltd. Address before: 250002 Shandong Province, Ji'nan City District Shungeng Road No. 217 NINETOWNS Shangdu office building room 324 Patentee before: Sun Zhiqiang |